9-69205229-G-C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_004817.4(TJP2):c.61-7319G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000631 in 1,537,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004817.4 intron
Scores
Clinical Significance
Conservation
Publications
- cholestasis, progressive familial intrahepatic, 4Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
- familial hypercholanemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nonsyndromic genetic hearing lossInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypercholanemia, familial 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004817.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TJP2 | NM_004817.4 | MANE Select | c.61-7319G>C | intron | N/A | NP_004808.2 | |||
| TJP2 | NM_001170416.2 | c.68G>C | p.Gly23Ala | missense | Exon 1 of 23 | NP_001163887.1 | |||
| TJP2 | NM_001369875.1 | c.68G>C | p.Gly23Ala | missense | Exon 1 of 23 | NP_001356804.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TJP2 | ENST00000377245.9 | TSL:1 MANE Select | c.61-7319G>C | intron | N/A | ENSP00000366453.4 | |||
| ENSG00000285130 | ENST00000642889.1 | c.448-7319G>C | intron | N/A | ENSP00000493780.1 | ||||
| TJP2 | ENST00000348208.9 | TSL:1 | c.61-7319G>C | intron | N/A | ENSP00000345893.4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152206Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000430 AC: 6AN: 139494 AF XY: 0.0000401 show subpopulations
GnomAD4 exome AF: 0.0000664 AC: 92AN: 1384918Hom.: 0 Cov.: 33 AF XY: 0.0000615 AC XY: 42AN XY: 683384 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74364 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Gly23Ala variant in TJP2 has not been previously reported in individuals w ith hearing loss, but has been identified in 1/7628 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs3718 68876). Computational prediction tools and conservation analyses suggest that th is variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Gly23Ala variant is uncertain.
not provided Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at